Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity

Nutrition Research

Volumn 33, Issue 11, 2013, Pages 971-981

  Wang, Bin ^a   Sun, Jin ^a   Li, Xianghui ^a   Zhou, Qingqing ^a   Bai, Jing ^a   Shi, Yonghui ^a   Le, Guowei ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

High fat diet induced obesity; Inflammation; Mice; Oxidative stress; Regulatory T cells; Resveratrol

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; RESVERATROL; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CTLA4 GENE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DIET SUPPLEMENTATION; DOWN REGULATION; FOXP3 GENE; GENE EXPRESSION; IL7R GENE; IN VIVO STUDY; INFLAMMATION; LIPID DIET; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; TGF BETA GENE; TH1 CELL; TH2 CELL; UPREGULATION; WEIGHT REDUCTION;

MUS;

AHR; ARYL HYDROCARBON RECEPTOR; CAT; CATALASE; CTLA-4; CYP1A1; CYTOCHROME P450 1A1; CYTOTOXIC T LYMPHOCYTE-ASSOCIATED ANTIGEN-4; DIET RESISTANT; DIO; DR; ELISA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FORKHEAD BOX P3; FOXP3; GLUTATHIONE PEROXIDASE; GLUTATHIONE/GLUTATHIONE DISULFIDE; GSH-PX; GSH/GSSG; HFD; HIGH-FAT DIET; HIGH-FAT DIET-INDUCED OBESE; HIGH-FAT DIET-INDUCED OBESITY; IL-1; IL7R; INFLAMMATION; INTERLEUKIN 1; INTERLEUKIN-7 RECEPTOR; MABS; MALONDIALDEHYDE; MATRIX METALLOPEPTIDASE 9; MCP-1; MDA; MESSENGER RNA; MICE; MMP-9; MONOCLONAL ANTIBODIES; MONOCYTE CHEMOTACTIC PROTEIN-1; MRNA; NAD(P)H DEHYDROGENASE [QUINONE 1]; NF-ΚB; NQO1; NUCLEAR FACTOR ΚB; OXIDATIVE STRESS; PBMCS; PERIPHERAL BLOOD MONONUCLEAR CELLS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Γ; PPARΓ; QRT-PCR; QUANTITATIVE REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REGULATORY T CELLS; RESVERATROL; TAC; TGF-Β; TNF-Α; TOTAL ANTIOXIDANT CAPACITY; TRANSFORMING GROWTH FACTOR Β; TREGS; TUMOR NECROSIS FACTOR Α; UDP GLUCURONOSYLTRANSFERASE 1A1; UGT1A1;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BODY WEIGHT; CYTOKINES; DIET, HIGH-FAT; DIETARY FATS; DIETARY SUPPLEMENTS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; OBESITY; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; RECEPTORS, ARYL HYDROCARBON; SPLEEN; STILBENES; T-LYMPHOCYTES, REGULATORY;

EID: 84886431966     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2013.07.016     Document Type: Article

References (78)

1. Stefanska B., Karlic H., Varga F., Fabianowska-Majewska K., Haslberger A. Epigenetic mechanisms in anti-cancer actions of bioactive food components-the implications in cancer prevention. Br J Pharmacol 2012, 167:279-297.
2. Willett W.C. Diet and health: what should we eat?. Science 1994, 264:532-537.
3. Speciale A., Chirafisi J., Saija A., Cimino F. Nutritional antioxidants and adaptive cell responses: an update. Curr Mol Med 2011, 11:770-789.
4. Poussier B., Cordova A.C., Becquemin J.P., Sumpio B.E. Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. J Vasc Surg 2005, 42:1190-1197.
5. Signorelli P., Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 2005, 16:449-466.
6. Estrov Z., Shishodia S., Faderl S., Harris D., Van Q., Kantarjian H.M., et al. Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 2003, 102:987-995.
7. Conway B., Rene A. Obesity as a disease: no lightweight matter. Obes Rev 2004, 5:145-151.
8. Blundell J.E., Stubbs R.J., Golding C., Croden F., Alam R., Whybrow S., et al. Resistance and susceptibility to weight gain: individual variability in response to a high-fat diet. Physiol Behav 2005, 86:614-622.
9. Xin X., Storlien L.H., Huang X.F. Hypothalamic c-fos-like immunoreactivity in high-fat diet-induced obese and resistant mice. Brain Res Bull 2000, 52:235-242.
10. Huang X.F., Han M., Storlien L.H. The level of NPY receptor mRNA expression in diet-induced obese and resistant mice. Mol Brain Res 2003, 115:21-28.
11. Li Z., Soloski M.J., Diehl A.M. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 2005, 42:880-885.
12. Lin S., Thomas T.C., Storlien L.H., Huang X.F. Development of high fat diet induced obesity and leptin resistance in C57BL/6J mice. Int J Obes 2000, 24:639-646.
13. Harikumar K.B., Aggarwal B.B. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 2008, 7:1020-1035.
14. Li W.G., Zhang X.Y., Wu Y.J., Tian X. Anti-inflammatory effect and mechanism of proanthocyanidins from grape seeds. Acta Pharmacol Sin 2001, 22:1117-1120.
15. Yang R.L., Li W., Shi Y.H., Le G.W. Lipoic acid prevents high-fat diet-induced dyslipidemia and oxidative stress: a microarray analysis. Nutrition 2008, 24:582-588.
16. Huang X.F., Han M., Storlien L. Differential expression of 5-HT2A and 5-HT2C receptor mRNA in mice prone, or resistant, to chronic high-fat diet-induced obesity. Mol Brain Res 2004, 127:39-47.
17. Levin B.E., Keesey R.E. Defense of differing body weight set points in diet-induced obese and resistant rats. Am J Physiol 1998, 274:R412-19.
18. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on high-calorie diet. Nature 2006, 444:337-342.
19. Szkudelska K., Szkudelski T. Resveratrol, obesity and diabetes. Eur J Pharmacol 2010, 635:1-8.
20. Gayatridevi S., Jayalakshmi S.K., Sreeramulu K. Salicylic acid is a modulator of catalase isozymes in chickpea plants infected with Fusarium oxysporum f. sp. Ciceri. Plant Physiol Biochem 2012, 52:154-161.
21. Goth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 1991, 196:143-151.
22. Feng R., He W., Ochi H. A new murine oxidative stress model associated with senescence. Mech Ageing Dev 2001, 122:547-559.
23. Hafeman D.G., Sunde R.A., Hoekstra W.G. Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J Nutr 1974, 104:580-587.
24. Senft A.P., Dalton T.P., Shertzer H.G. Determining glutathione and glutathione disulfide using the fluorescence probe o-phthalaldehyde. Anal Biochem 2000, 280:80-86.
25. Grune T., Berger M.M. Markers of oxidative stress in ICU clinical settings: present and future. Curr Opin Clin Nutr Metab Care 2007, 10:712-717.
26. Sun Y., Li H., Langnas A.N., Zhao Y. Altered allogeneic immune responses in middle-aged mice. Cell Mol Immunol 2004, 1:440-446.
27. 2+ channel regulation of Th1-type proliferation of splenic lymphocytes induced by Walker 256 tumor development in rats. Eur J Pharmacol 2006, 549:179-184.
28. McNeill A., Spittle E., Backstrom B.T. Partial depletion of CD69 low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61. Scand J Immunol 2007, 65:63-69.
29. Maczynska I., Millo B., Ratajczak-Stefanska V., Maleszka R., Szych Z., Kurpisz M., et al. Proinflammatory cytokine (IL-1beta, IL-6, IL-12, IL-18 and TNF-alpha) levels in sera of patients with subacute cutaneous lupus erythematosus (SCLE). Immunol Lett 2006, 102:79-82.
30. Cui J., Le G.W., Yang R.L., Shi Y.H. Lipoic acid attenuates high fat diet-induced chronic oxidative stress and immunosuppression in mice jejunum: a microarray analysis. Cell Immunol 2009, 260:44-50.
31. Xiao Y., Cui J., Shi Y.H., Sun J., Wang Z.P., Le G.W. Effects of duodenal redox status on calcium absorption and related genes expression in high-fat diet-fed mice. Nutrition 2010, 26:1188-1194.
32. Cui J., Xiao Y., Shi Y.H., Le G.W., Miao X.Y. Comparative proteome analysis of splenic lymphocytes in long-term high-fat diet and dietary supplement with lipoic acid mice. Cell Immunol 2010, 264:156-162.
33. Sakai T., Taki T., Nakamoto A., Shuto E., Tsutsumi R., Toshimitsu T., et al. Lactobacillus plantarum OLL2712 regulates glucose metabolism in C57BL/6 mice fed a high-fat diet. J Nutr Sci Vitaminol 2013, 59:144-147.
34. Choi K.M., Lee Y.S., Shin D.M., Lee S., Yoo K.S., Lee M.K., et al. Green tomato extract attenuates high-fat-diet-induced obesity through activation of the AMPK pathway in C57BL/6 mice. J Nutr Biochem 2013, 24:335-342.
35. Rayalam S., Della-Fera M.A., Yang J.Y., Park H.J., Ambati S., Baile C.A. Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. J Nutr 2007, 137:2668-2673.
36. Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., Machado R., et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 2004, 429:771-776.
37. Bai L., Pang W.J., Yang Y.J., Yang G.S. Modultion of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol Cell Biochem 2008, 307:129-140.
38. Cohen H.Y., Miller C., Bitterman K.J., Wall N.R., Hekking B., Kessler B., et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004, 305:390-392.
39. Hardie D.G., Pan D.A. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 2002, 30:1064-1070.
40. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
41. Beher D., Wu J., Cumine S., Kim K.W., Lu S.C., Atangan L., et al. Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem Biol Drug Des 2009, 74:619-624.
42. Pacholec M., Bleasdale J.E., Chrunyk B., Cunningham D., Flynn D., Garofalo R.S., et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 2010, 285:8340-8351.
43. Park S.J., Ahmad F., Philp A., Baar K., Williams T., Luo H., et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012, 148:421-433.
44. Hubbard B.P., Gomes A.P., Dai H., Li J., Case A.W., Considine T., et al. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 2013, 339:1216-1269.
45. Zang M., Xu S., Maitland-Toolan K.A., Zuccollo A., Hou X., Jiang B., et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006, 55:2180-2191.
46. Rivera L., Morón R., Zarzuelo A., Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 2009, 77:1053-1063.
47. + regulatory T cells. Hepatology 2005, 42:193-199.
48. Mayeux P.R. Pathobiology of lipopolysaccharide. J Toxicol Environ Health 1997, 51:415-435.
49. Ma X., Hua J., Mohamood A.R., Hamad A.R., Ravi R., Li Z. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology 2007, 46:1519-1929.
50. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004, 24:2783-2840.
51. Fuente M.D.L., Victor V.M. Antioxidants as modulators of immune response. Immunol Cell Biol 2000, 78:49-54.
52. Leung S., Liu X., Fang L., Chen X., Guo T., Zhang J. The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease. Cell Mol Immunol 2010, 7:182-189.
53. Afzali B., Mitchell P., Lechler R.I., John S., Lombardi G. Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol 2010, 159:120-130.
54. Lanzilli G., Cottarelli A., Nicotera G., Guida S., Ravagnan G., Fuggetta M.P. Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation 2012, 35:240-248.
55. Gao X.Z., Komai-Koma M., Leung B.P., Howe H.S., McSharry C., McInnes I.B., et al. Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Ann Rheum Dis 2012, 71:129-135.
56. Petro T.M. Regulatory role of resveratrol on Th17 in autoimmune disease. Int Immunopharmacol 2011, 11:310-318.
57. Singh N., Singh U., Nagarkatti P., Nagarkatti M. Resveratrol ameliorates lupus by epigenetic modulation of Foxp3 and IL-17 genes resulting in differential regulation of regulatory T cells and Th17 cells via activation of aryl hydrocarbon receptor (P5129). J Immunol 2013, 190:137.6.
58. Yssel H., Groux H. Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases. Int Arch Allergy Immunol 2000, 121:10-18.
59. Marier J.F., Chen K., Prince P., Scott G., Del Castillo J.R., Vachon P. Production of ex vivo lipopolysaccharide induced tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 is suppressed by trans-resveratrol in a concentration-dependent manner. Can J Vet Res 2005, 69:151-154.
60. Wallace F.A., Miles E.A., Evans C., Stock T.E., Yaqoob P., Calder P.C. Dietary fatty acids influence the production of Th1- but not Th2-type cytokines. J Leukoc Biol 2001, 69:449-457.
61. Kleemann R., Scott F.W., Wörz-Pagenstert U., Ratnayake W.M.N., Kolb H. Impact of dietary fat on Th1/Th2 cytokine gene expression in the pancreas and gut of diabetes-prone BB rats. J Autoimmun 1998, 11:97-103.
62. + T cell. Int Immunopharmacol 2006, 6:1424-1430.
63. Zhou X., Kong N., Wang J., Fan H., Zou H., Horwitz D., et al. Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. J Immunol 2010, 185:2675-2679.
64. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699.
65. + regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci USA 2004, 101:4572-4577.
66. Read S., Malmstrom V., Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000, 192:295-302.
67. + T cells. J Immunol 2004, 173:6526-6531.
68. + regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease. Br J Dermatol 2008, 158:1197-1209.
69. Lu L.Y., Chu J.J., Lu P.J., Sung P.K., Hsu C.M., Tseng J.C. Expression of intracellular transforming growth factor-beta1 in CD4(+)CD25(+) cells in patients with systemic lupus erythematosus. Immunol Infect 2008, 41:165-173.
70. Casper R.F., Quesne M., Rogers I.M., Shirota T., Jolivet A., Milgrom E., et al. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol 1999, 56:784-790.
71. Singh N.P., Hegde V.L., Hofseth L.J., Nagarkatti M., Nagarkatti P. Resveratrol (trans-3, 5, 4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis (EAE) primarily via induction of apoptosis in T cells involving activation of AhR and ER. Mol Pharmacol 2007, 72:1508-1521.
72. Schulz V.J., Smit J.J., Willemsen K.J., Fiechter D., Hassing I., Bleumink R., et al. Activation of the aryl hydrocarbon receptor suppresses sensitization in a mouse peanut allergy model. Toxicol Sci 2011, 123:491-500.
73. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., et al. Control of T (reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
74. + regulatory T cells. Toxicol Lett 2012, 215:100-109.
75. Veillard N.R., Steffens S., Burger F., Pelli G., Mach F. Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogenesis in mice. Arterioscler Thromb Vasc Biol 2004, 24:2339-2344.
76. Ferrero M.E., Bertelli A.E., Fulgenzi A., Pellegatta F., Corsi M.M., Bonfrate M., et al. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am J Clin Nutr 1998, 68:1208-1214.
77. Pellegatta F., Bertelli A.A., Staels B., Duhem C., Fulgenzi A., Ferrero M.E. Different short-and long-term effects of resveratrol on nuclear factor-kappaB phosphorylation and nuclear appearance in human endothelial cells. Am J Clin Nutr 2003, 77:1220-1228.
78. Jeon B.T., Jeong E.A., Shin H.J., Lee Y., Lee D.H., Kim H.J., et al. Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 2012, 61:1444-14454.